JD.com Announces First Quarter 2024 Results
GlobeNewswire
BEIJING, May 16, 2024 (GLOBE NEWSWIRE) -- JD.com, Inc. (NASDAQ: JD and HKEX: 9618 (HKD counter) and 89618 (RMB counter), the..
BEIJING, May 16, 2024 (GLOBE NEWSWIRE) -- JD.com, Inc. (NASDAQ: JD and HKEX: 9618 (HKD counter) and 89618 (RMB counter), the..
BEIJING, March 06, 2024 (GLOBE NEWSWIRE) -- JD.com, Inc. (NASDAQ: JD and HKEX: 9618 (HKD counter) and 89618 (RMB counter)), a..
Company maintains priority focus on clinical programs to develop a novel functional cure for hepatitis B viral (HBV) infection and..